Group 4 Pulmonary hypertension due to CTEPH ‐ PDE5i vs placebo
Improvement in WHO functional class · people with pulmonary hypertension due to CTEPH
Group 4 Pulmonary hypertension due to CTEPH ‐ PDE5i showed no clear difference in improvement in WHO functional class compared with placebo (low certainty).
1 finding from 1 review
- OR 17.18 [0.78, 380.84]1 study · 19 participantsLow